Fig. 1From: Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsyBlood plasma ctDNA and tumour tissue sequencing reveals rapid response to FOLFIRI+Bevacizumab and rapid progression after chemotherapyBack to article page